Actively Recruiting
ALI/ARDS Clinical Sub-phenotyping Study
Led by China-Japan Friendship Hospital · Updated on 2025-02-12
1500
Participants Needed
1
Research Sites
106 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
1. Construct a structured clinical data and biosample information platform for Chinese patients with acute lung injury/ acute respiratory distress syndrome. 2. By deciphering the heterogeneity of patients with acute lung injury/ acute respiratory distress syndrome, achieve clinical, longitudinal physiological, and biological sub-phenotyping to guide individualized precision treatment and improve prognosis.
CONDITIONS
Official Title
ALI/ARDS Clinical Sub-phenotyping Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meet the diagnostic criteria for Acute Respiratory Distress Syndrome (ARDS) according to the updated global definition in 2023.
- The patient or their legal representative signs an informed consent form.
You will not qualify if you...
- Individuals aged less than 18 years old.
- Those who refuse to participate in the study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Jingen Xia
Beijing, China
Actively Recruiting
Research Team
J
Jingen Xia, M.D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here